Cutia Therapeutics (HKG:2487)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.8600
+0.0100 (1.18%)
Oct 9, 2026, 3:26 PM HKT

Cutia Therapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3191,6502,2563,338--
Market Cap Growth
-89.78%-26.86%-32.43%---
Enterprise Value
-871,2211,4231,954--
Last Close Price
0.854.547.0810.98--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.834.417.5822.02--
PB Ratio
0.391.682.172.25--
P/TBV Ratio
0.391.692.192.26--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-3.264.7812.89--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.390.360.330.18-2.11-2.87
Net Debt / Equity Ratio
-0.49-0.53-0.57-0.76-1.24-1.13
Net Debt / EBITDA Ratio
1.631.691.282.02-5.19-5.12
Net Debt / FCF Ratio
1.541.561.192.35-4.18-4.84
Asset Turnover
0.300.250.180.090.01-
Inventory Turnover
3.942.552.272.040.31-
Quick Ratio
3.713.673.035.3013.9671.62
Current Ratio
3.853.873.365.5614.8072.82
Return on Equity (ROE)
-38.30%-36.58%-37.34%-3823.41%--
Return on Assets (ROA)
-14.05%-14.29%-18.61%-21.39%-13.14%-
Return on Capital Employed (ROCE)
-28.60%-29.80%-43.10%-37.20%-22.60%-12.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-101.75%-22.95%-20.47%-64.81%--
FCF Yield
-82.71%-20.36%-21.96%-14.42%--
Buyback Yield / Dilution
-12.39%-7.70%-50.13%-155.62%--